Further evidence that melanocortins prevent myocardial reperfusion injury by activating melanocortin MC3 receptors

European Journal of Pharmacology

Volumn 477, Issue 3, 2003, Pages 227-234

  Mioni, Chiara ^a   Giuliani, Daniela ^a   Cainazzo, Maria Michela ^a   Leone, Sheila ^a   Iannone, Carla ^a   Bazzani, Carla ^a   Grieco, Paolo ^b   Novellino, Ettore ^b   Tomasi, Aldo ^a   Bertolini, Alfio ^a   Guarini, Salvatore ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

MSH ( melanocyte stimulating hormone); FMRFamide like (Phe Met Arg Phe NH2 like) peptide; Melanocortin MC 3 receptor; Myocardium; Oxygen free radical; Reperfusion injury

Indexed keywords

ARGININE; GAMMA INTERMEDIN; MELANOCORTIN 3 RECEPTOR; N ACETYL ALPHA INTERMEDIN[4-10]CYCLO[4 NORLEUCINE 5 ASPARTIC ACID 7 [3 (2 NAPHTHYL)ALANINE] 10 LYSINAMIDE]; PHENYLALANINE; TETRACOSACTIDE;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; HEART DEATH; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; RAT; RECEPTOR INTRINSIC ACTIVITY; REPERFUSION INJURY; SPECIES COMPARISON;

ALPHA-MSH; ANIMALS; CORONARY DISEASE; COSYNTROPIN; FEMALE; FMRFAMIDE; GAMMA-MSH; HYPOTENSION; INJECTIONS, INTRAVENOUS; LIDOCAINE; MALE; MELANOCYTE-STIMULATING HORMONES; MYOCARDIAL REPERFUSION INJURY; RATS; RATS, WISTAR; RECEPTOR, MELANOCORTIN, TYPE 3; SIGNAL TRANSDUCTION; TACHYCARDIA, VENTRICULAR; TIME FACTORS; VENTRICULAR FIBRILLATION;

EID: 12144286408     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(03)02184-8     Document Type: Article

References (56)

1. Allard M., Labrouche S., Nosjean A., Laguzzi R. Mechanisms underlying the cardiovascular responses to peripheral administration of NPFF in the rat. J. Pharmacol. Exp. Ther. 274:1995;577-583.
2. Altavilla D., Squadrito F., Campo G.M., Saitta A., Squadrito G., Quartarone C., Deodato B., Arlotta M., Ferlito M., Minutoli L., Urna G., Sardella A., Caputi A.P. The reduction of myocardial damage and leukocyte polymorphonuclear accumulation following coronary artery occlusion by the tyrosine kinase inhibitor tyrphostin AG 556. Life Sci. 67:2000;2615-2629.
3. Ar'Rajab A., Dawidson I., Fabia R. Reperfusion injury. New Horizons. 4:1996;224-234.
4. Bazzani C., Guarini S., Botticelli A.R., Zaffe D., Tomasi A., Bini A., Cainazzo M.M., Terrazza G., Mioni C., Bertolini A. Protective effect of melanocortin peptides in rat myocardial ischemia. J. Pharmacol. Exp. Ther. 297:2001;1082-1087.
5. Bazzani C., Mioni C., Ferrazza G., Cainazzo M.M., Bertolini A., Guarini S. Involvement of the central nervous system in the protective effect of melanocortins in myocardial ischaemia/reperfusion injury. Resuscitation. 52:2002;109-115.
6. Bernier M., Hearse D.J., Manning A.S. Reperfusion-induced arrhythmias and oxygen-derived free radicals: studies with "anti-free radical" interventions and a free-radical generating system in the isolated perfused rat heart. Circ. Res. 58:1986;331-340.
7. Bertolini A. The opioid/anti-opioid balance in shock: a new target for therapy in resuscitation. Resuscitation. 30:1995;29-42.
8. Bertolini A., Guarini S., Rompianesi E., Ferrari W. α-MSH and other ACTH fragments improve cardiovascular function and survival in experimental hemorrhagic shock. Eur. J. Pharmacol. 130:1986;19-26.
9. Bolli R. Oxygen-derived free radicals and postischemic myocardial dysfunction ('stunned myocardium'). J. Am. Coll. Cardiol. 1:1988;239-249.
10. Bolli R., Marban E. Molecular and cellular mechanisms of myocardial stunning. Physiol. Rev. 2:1999;609-634.
11. Catania A., Airaghi L., Colombo G., Lipton J.M. α-Melanocyte- stimulating hormone in normal human physiology and disease states. Trends Endocrinol. Metab. 11:2000;304-308.
12. Chandrasekar B., Freeman G.L. Induction of nuclear factor kappaB and activation protein 1 in postischemic myocardium. FEBS Lett. 1:1997;30-34.
13. Dhalla N.S., Elmoselhi A.B., Hata T., Makino N. Status of myocardial antioxidants in ischemia-reperfusion injury. Cardiovasc. Res. 3:2000;446-456.
14. 2-MSH)-like immunoreactivity in neuronal elements in the brain and peripheral tissues of the rat. Brain Res. 731:1996;182-189.
15. Frangogiannis N.G., Smith C.W., Entman M.L. The inflammatory response in myocardial infarction. Cardiovasc. Res. 53:2002;31-47.
16. Getting S.J. Melanocortin peptides and their receptors: new targets for anti-inflammatory therapy. Trends Pharmacol. Sci. 23:2002;447-449.
17. 3 receptor selectivity. J. Med. Chem. 43:2000;4998-5002.
18. Guarini S., Bazzani C., Mattera Ricigliano G.M., Bini A., Tomasi A., Bertolini A. Influence of ACTH-(1-24) on free radical levels in the blood of haemorrhage-shocked rats: direct ex vivo detection by electron spin resonance spectrometry. Br. J. Pharmacol. 119:1996;29-34.
19. Guarini S., Bazzani C., Bertolini A. Resuscitating effect of melanocortin peptides after prolonged respiratory arrest. Br. J. Pharmacol. 121:1997;1454-1460.
20. Guarini S., Bazzani C., Cainazzo M.M., Mioni C., Ferrazza G., Vergoni A.V., Schiöth H.B., Wikberg J.E.S., Bertolini A. Evidence that melanocortin 4 receptor mediates hemorrhagic shock reversal caused by melanocortin peptides. J. Pharmacol. Exp. Ther. 291:1999;1023-1027.
21. 3 receptors are involved in the protective effect of melanocortins in myocardial ischaemia/reperfusion-induced arrhythmias. Naunyn-Schmiedeberg's Arch. Pharmacol. 366:2002;177-182.
22. 2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors. J. Med. Chem. 38:1995;3454-3461.
23. Huang Q., Tatro J.B. α-Melanocyte stimulating hormone suppresses intracerebral tumor necrosis factor-α and interleukin-1β gene expression following transient cerebral ischemia in mice. Neurosci. Lett. 334:2002;186-190.
24. Kivipelto L., Majane E.A., Yang H.-Y.T., Panula P. Immunohistochemical distribution and partial characterization of FLFQPQRFamide like peptides in the central nervous system of rats. J. Comp. Neurol. 286:1989;269-287.
25. Kivipelto L., Aarnisalo A.A., Panula P. Neuropeptide FF is colocalized with cathecolamine-synthesizing enzymes in neurons of the nucleus of the solitari tract. Neurosci. Lett. 143:1992;190-194.
26. Kupatt C., Habazettl H., Goedecke A., Wolf D.A., Zahler S., Boekstegers P., Kelly R.A., Becker B.F. Tumor necrosis factor-alpha contributes to ischemia- and reperfusion-induced endothelial activation in isolated hearts. Circ. Res. 4:1999;392-400.
27. Kurz T., Richardt G., Seyfarth M., Schömig A. Nonexocytotic noradrenaline release induced by pharmacological agents or anoxia in human cardiac tissue. Naunyn-Schmiedeberg's Arch. Pharmacol. 354:1996;7-16.
28. Lefer D.J., Granger D.N. Oxidative stress and cardiac disease. Am. J. Med. 4:2000;315-323.
29. Lipton J.M., Catania A. Anti-inflammatory actions of the neuroimmunomodulator α-MSH. Immunol. Today. 18:1997;140-145.
30. Lucchesi B.R. Modulation of leukocyte-mediated myocardial reperfusion injury. Annu. Rev. Physiol. 52:1990;561-566.
31. Maczewski M., Beresewicz A. The role of endothelin, protein kinase C and free radicals in the mechanism of the post-ischemic endothelial dysfunction in guinea-pig hearts. J. Mol. Cell. Cardiol. 32:2000;297-310.
32. Majane E.A., Panula P., Yang H.-Y.T. Rat brain regional distribution and spinal cord neuronal pathway of FLFQPQRF-NH2, a mammalian FMRF-NH2-like peptide. Brain Res. 494:1989;1-12.
33. Manning A.S., Hearse D.J. Reperfusion-induced arrhythmias: mechanisms and prevention. J. Mol. Cell. Cardiol. 16:1984;497-518.
34. Manning A.S., Crome R., Klein N., Hearse D.J., Maguire M.E. Dissociation between reperfusion induced arrhythmias and increases in ventricular alpha 1 receptor density in the anaesthetised rat. Cardiovasc. Res. 23:1989;852-858.
35. 2. Life Sci. 31:1982;2555-2561.
36. 2-MSH) for inducing cardiovascular effects in conscious rats. Br. J. Pharmacol. 131:2000;1468-1474.
37. Noera G., Lamarra M., Guarini S., Bertolini A. Survival rate after early treatment for acute type-A aortic dissection with ACTH-(1-24). Lancet. 358:2001;469-470.
38. Noera G., Lamarra M., Guarini S., Bertolini A. ACTH analogue in treatment of acute aortic dissection - authors' reply. Lancet. 359:2002;168-169.
39. Obata T., Yamanaka Y. Prazosin attenuates hydroxyl radical generation in the rat myocardium. Eur. J. Pharmacol. 379:1999;161-166.
40. O'Donohue T.L., Bishop J.F., Chronwall B.M., Groome J., Watson W.H. Characterization and distribution of FMRFamide immunoreactivity in the rat central nervous system. Peptides. 5:1984;563-568.
41. Pinelli G., Chesi G., Di Donato C., Reverzani A., Marani L. Preliminary data on the use of ACTH-(1-24) in human shock conditions. Resuscitation. 18:1989;149-150.
42. Reilly P.M., Schiller H.J., Bulkley G.B. Pharmacological approach to tissue injury mediated by free radicals and other reactive oxygen metabolites. Am. J. Surg. 161:1991;488-503.
43. Rona G. Catecholamine cardiotoxicity. J. Mol. Cell. Cardiol. 17:1985;291-306.
44. Schömig A., Dart A.M., Dietz R., Mayer E., Küber W. Release of endogenous catecholamines in the ischemic myocardium of the rat. Part A: locally mediated release. Circ. Res. 55:1984;689-701.
45. Selye H., Bajusz E., Grassos S., Mendell P. Simple techniques for the surgical occlusion of coronary vessels in the rat. Angiology. 11:1960;398-407.
46. Seyfarth M., Feng Y., Hagl S., Sebening F., Richardt G., Schömig A. Effect of myocardial ischemia on stimulation-evoked noradrenaline release. Modulated neurotransmission in rat, guinea pig, and human cardiac tissue. Circ. Res. 73:1993;496-502.
47. Squadrito F., Guarini S., Altavilla D., Squadrito G., Campo G.M., Arlotta M., Quartarone C., Saitta A., Cucinotta D., Bazzani C., Cainazzo M.M., Mioni C., Bertolini A., Caputi A.P. Adrenocorticotropin reverses vascular dysfunction and protects against splanchnic artery occlusion shock. Br. J. Pharmacol. 128:1999;816-822.
48. Thiemermann C., Al-damluji S., Hecker M., Vane J.R. FMRFamide and L-Arg-L-Phe increase blood pressure and heart rate in the anaesthetised rat by central stimulation of the sympathetic nervous system. Biochem. Biophys. Res. Commun. 175:1991;318-324.
49. Tortolani A.J., Powell S.R., Misik V., Weglicki W.B., Pogo G.J., Kramer J.H. Detection of alkoxyl and carboncentered free radicals in coronary sinus blood from patients undergoing elective cardioplegia. Free Radic. Biol. Med. 14:1993;421-426.
50. Van Bergen P., Janssen P.M.L., Hoogerhout P., De Wildt D.J., Versteeg D.H.G. Cardiovascular effects of γ-MSH/ACTH-like peptides: structure-activity relationship. Eur. J. Pharmacol. 294:1995;795-803.
51. 2-MSH and ACTH-(1-24). Br. J. Pharmacol. 120:1997;1561-1567.
52. Versteeg D.H.G., Van Bergen P., Adan R.A.H., De Wildt D.J. Melanocortins and cardiovascular regulation. Eur. J. Pharmacol. 360:1998;1-14.
53. Walker M.J.A., Curtis M.J., Hearse D.J., Campbell R.W.F., Janse M.J., Yellon D.M., Cobbe S.M., Coker S.J., Harness J.B., Harron D.W.G., Higgins A.J., Julian D.G., Lab M.J., Manning A.S., Northover B.J., Parratt J.R., Riemersma R.A., Riva E., Russel D.C., Sheridan D.J., Winslow E., Woodward B. The Lambeth conventions: guidelines for the study of arrhythmias in ischaemia, infarction, and reperfusion. Cardiovasc. Res. 22:1988;447-455.
54. Wikberg J.E.S., Muceniece R., Mandrika I., Prusis P., Post C., Skottner A. New aspects on the melanocortins and their receptors. Pharmacol. Res. 42:2000;393-420.
55. Wilson J.F. Low permeability of the blood-brain barrier to nanomolar concentrations of immunoreactive alpha-melanotropin. Psychopharmacology. 96:1988;262-266.
56. Yamada M., Hearse D.J., Curtis M.J. Reperfusion and readmission of oxygen. Pathophysiological relevance of oxygen-derived free radicals to arrhythmogenesis. Circ. Res. 67:1990;1211-1224.